ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alcohol Addiction Therapeutics Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-17G14036
Home | Market Reports | Health| Nursing
Global Alcohol Addiction Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Alcohol Addiction Therapeutics Market Research Report 2024

Code: QYRE-Auto-17G14036
Report
August 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H Lundbeck A S
Heptares Therapeutics Ltd
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc

Alcohol Addiction Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Alcohol Addiction Therapeutics Market

Alcohol Addiction Therapeutics Market

The global Alcohol Addiction Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alcohol Addiction Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alcohol Addiction Therapeutics.

Report Scope

The Alcohol Addiction Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alcohol Addiction Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alcohol Addiction Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Alcohol Addiction Therapeutics Market Report

Report Metric Details
Report Name Alcohol Addiction Therapeutics Market
CAGR 5%
Segment by Type
  • CM-1212
  • CTDP-002
  • A-705253
  • ABT-436
  • ADX-71441
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca Plc, BioCorRx Inc, Bionex Pharmaceuticals LLC, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Curemark LLC, Eli Lilly and Company, Ethypharm SA, H. Lundbeck A/S, Heptares Therapeutics Ltd, Indivior Plc, Kinnov Therapeutics SAS, Kyorin Pharmaceutical Co Ltd, Lohocla Research Corp, Montisera Ltd, Omeros Corp, Opiant Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Alcohol Addiction Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alcohol Addiction Therapeutics Market report?

Ans: The main players in the Alcohol Addiction Therapeutics Market are AstraZeneca Plc, BioCorRx Inc, Bionex Pharmaceuticals LLC, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Curemark LLC, Eli Lilly and Company, Ethypharm SA, H. Lundbeck A/S, Heptares Therapeutics Ltd, Indivior Plc, Kinnov Therapeutics SAS, Kyorin Pharmaceutical Co Ltd, Lohocla Research Corp, Montisera Ltd, Omeros Corp, Opiant Pharmaceuticals Inc

What are the Application segmentation covered in the Alcohol Addiction Therapeutics Market report?

Ans: The Applications covered in the Alcohol Addiction Therapeutics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Alcohol Addiction Therapeutics Market report?

Ans: The Types covered in the Alcohol Addiction Therapeutics Market report are CM-1212, CTDP-002, A-705253, ABT-436, ADX-71441, Others

Recommended Reports

Mental Health Therapeutics

Disease-Specific Therapeutics

Addiction and Neurology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CM-1212
1.2.3 CTDP-002
1.2.4 A-705253
1.2.5 ABT-436
1.2.6 ADX-71441
1.2.7 Others
1.3 Market by Application
1.3.1 Global Alcohol Addiction Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alcohol Addiction Therapeutics Market Perspective (2019-2030)
2.2 Alcohol Addiction Therapeutics Growth Trends by Region
2.2.1 Global Alcohol Addiction Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alcohol Addiction Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Alcohol Addiction Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Alcohol Addiction Therapeutics Market Dynamics
2.3.1 Alcohol Addiction Therapeutics Industry Trends
2.3.2 Alcohol Addiction Therapeutics Market Drivers
2.3.3 Alcohol Addiction Therapeutics Market Challenges
2.3.4 Alcohol Addiction Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alcohol Addiction Therapeutics Players by Revenue
3.1.1 Global Top Alcohol Addiction Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alcohol Addiction Therapeutics Revenue
3.4 Global Alcohol Addiction Therapeutics Market Concentration Ratio
3.4.1 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alcohol Addiction Therapeutics Revenue in 2023
3.5 Alcohol Addiction Therapeutics Key Players Head office and Area Served
3.6 Key Players Alcohol Addiction Therapeutics Product Solution and Service
3.7 Date of Enter into Alcohol Addiction Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alcohol Addiction Therapeutics Breakdown Data by Type
4.1 Global Alcohol Addiction Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Alcohol Addiction Therapeutics Forecasted Market Size by Type (2025-2030)
5 Alcohol Addiction Therapeutics Breakdown Data by Application
5.1 Global Alcohol Addiction Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alcohol Addiction Therapeutics Market Size (2019-2030)
6.2 North America Alcohol Addiction Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alcohol Addiction Therapeutics Market Size by Country (2019-2024)
6.4 North America Alcohol Addiction Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alcohol Addiction Therapeutics Market Size (2019-2030)
7.2 Europe Alcohol Addiction Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alcohol Addiction Therapeutics Market Size by Country (2019-2024)
7.4 Europe Alcohol Addiction Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alcohol Addiction Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Alcohol Addiction Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alcohol Addiction Therapeutics Market Size (2019-2030)
9.2 Latin America Alcohol Addiction Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alcohol Addiction Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Alcohol Addiction Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alcohol Addiction Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Alcohol Addiction Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Detail
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Introduction
11.1.4 AstraZeneca Plc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.1.5 AstraZeneca Plc Recent Development
11.2 BioCorRx Inc
11.2.1 BioCorRx Inc Company Detail
11.2.2 BioCorRx Inc Business Overview
11.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Introduction
11.2.4 BioCorRx Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.2.5 BioCorRx Inc Recent Development
11.3 Bionex Pharmaceuticals LLC
11.3.1 Bionex Pharmaceuticals LLC Company Detail
11.3.2 Bionex Pharmaceuticals LLC Business Overview
11.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Introduction
11.3.4 Bionex Pharmaceuticals LLC Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.3.5 Bionex Pharmaceuticals LLC Recent Development
11.4 Cerecor Inc
11.4.1 Cerecor Inc Company Detail
11.4.2 Cerecor Inc Business Overview
11.4.3 Cerecor Inc Alcohol Addiction Therapeutics Introduction
11.4.4 Cerecor Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.4.5 Cerecor Inc Recent Development
11.5 Chronos Therapeutics Ltd
11.5.1 Chronos Therapeutics Ltd Company Detail
11.5.2 Chronos Therapeutics Ltd Business Overview
11.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Introduction
11.5.4 Chronos Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.5.5 Chronos Therapeutics Ltd Recent Development
11.6 Corcept Therapeutics Inc
11.6.1 Corcept Therapeutics Inc Company Detail
11.6.2 Corcept Therapeutics Inc Business Overview
11.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Introduction
11.6.4 Corcept Therapeutics Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.6.5 Corcept Therapeutics Inc Recent Development
11.7 Curemark LLC
11.7.1 Curemark LLC Company Detail
11.7.2 Curemark LLC Business Overview
11.7.3 Curemark LLC Alcohol Addiction Therapeutics Introduction
11.7.4 Curemark LLC Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.7.5 Curemark LLC Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.8.5 Eli Lilly and Company Recent Development
11.9 Ethypharm SA
11.9.1 Ethypharm SA Company Detail
11.9.2 Ethypharm SA Business Overview
11.9.3 Ethypharm SA Alcohol Addiction Therapeutics Introduction
11.9.4 Ethypharm SA Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.9.5 Ethypharm SA Recent Development
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Detail
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Introduction
11.10.4 H. Lundbeck A/S Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.10.5 H. Lundbeck A/S Recent Development
11.11 Heptares Therapeutics Ltd
11.11.1 Heptares Therapeutics Ltd Company Detail
11.11.2 Heptares Therapeutics Ltd Business Overview
11.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Introduction
11.11.4 Heptares Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.11.5 Heptares Therapeutics Ltd Recent Development
11.12 Indivior Plc
11.12.1 Indivior Plc Company Detail
11.12.2 Indivior Plc Business Overview
11.12.3 Indivior Plc Alcohol Addiction Therapeutics Introduction
11.12.4 Indivior Plc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.12.5 Indivior Plc Recent Development
11.13 Kinnov Therapeutics SAS
11.13.1 Kinnov Therapeutics SAS Company Detail
11.13.2 Kinnov Therapeutics SAS Business Overview
11.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Introduction
11.13.4 Kinnov Therapeutics SAS Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.13.5 Kinnov Therapeutics SAS Recent Development
11.14 Kyorin Pharmaceutical Co Ltd
11.14.1 Kyorin Pharmaceutical Co Ltd Company Detail
11.14.2 Kyorin Pharmaceutical Co Ltd Business Overview
11.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Introduction
11.14.4 Kyorin Pharmaceutical Co Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.14.5 Kyorin Pharmaceutical Co Ltd Recent Development
11.15 Lohocla Research Corp
11.15.1 Lohocla Research Corp Company Detail
11.15.2 Lohocla Research Corp Business Overview
11.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Introduction
11.15.4 Lohocla Research Corp Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.15.5 Lohocla Research Corp Recent Development
11.16 Montisera Ltd
11.16.1 Montisera Ltd Company Detail
11.16.2 Montisera Ltd Business Overview
11.16.3 Montisera Ltd Alcohol Addiction Therapeutics Introduction
11.16.4 Montisera Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.16.5 Montisera Ltd Recent Development
11.17 Omeros Corp
11.17.1 Omeros Corp Company Detail
11.17.2 Omeros Corp Business Overview
11.17.3 Omeros Corp Alcohol Addiction Therapeutics Introduction
11.17.4 Omeros Corp Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.17.5 Omeros Corp Recent Development
11.18 Opiant Pharmaceuticals Inc
11.18.1 Opiant Pharmaceuticals Inc Company Detail
11.18.2 Opiant Pharmaceuticals Inc Business Overview
11.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Introduction
11.18.4 Opiant Pharmaceuticals Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024)
11.18.5 Opiant Pharmaceuticals Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Astrazeneca plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H Lundbeck A S
Heptares Therapeutics Ltd
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc
List of Tables
    Table 1. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of CM-1212
    Table 3. Key Players of CTDP-002
    Table 4. Key Players of A-705253
    Table 5. Key Players of ABT-436
    Table 6. Key Players of ADX-71441
    Table 7. Key Players of Others
    Table 8. Global Alcohol Addiction Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Alcohol Addiction Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Alcohol Addiction Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Alcohol Addiction Therapeutics Market Share by Region (2019-2024)
    Table 12. Global Alcohol Addiction Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Alcohol Addiction Therapeutics Market Share by Region (2025-2030)
    Table 14. Alcohol Addiction Therapeutics Market Trends
    Table 15. Alcohol Addiction Therapeutics Market Drivers
    Table 16. Alcohol Addiction Therapeutics Market Challenges
    Table 17. Alcohol Addiction Therapeutics Market Restraints
    Table 18. Global Alcohol Addiction Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Alcohol Addiction Therapeutics Market Share by Players (2019-2024)
    Table 20. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcohol Addiction Therapeutics as of 2023)
    Table 21. Ranking of Global Top Alcohol Addiction Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 22. Global 5 Largest Players Market Share by Alcohol Addiction Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Alcohol Addiction Therapeutics Product Solution and Service
    Table 25. Date of Enter into Alcohol Addiction Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Alcohol Addiction Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2019-2024)
    Table 29. Global Alcohol Addiction Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2025-2030)
    Table 31. Global Alcohol Addiction Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2019-2024)
    Table 33. Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2025-2030)
    Table 35. North America Alcohol Addiction Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Alcohol Addiction Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Alcohol Addiction Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Alcohol Addiction Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Europe Alcohol Addiction Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 40. Europe Alcohol Addiction Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Asia-Pacific Alcohol Addiction Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 43. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 44. Latin America Alcohol Addiction Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Latin America Alcohol Addiction Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Latin America Alcohol Addiction Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Middle East & Africa Alcohol Addiction Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 50. AstraZeneca Plc Company Detail
    Table 51. AstraZeneca Plc Business Overview
    Table 52. AstraZeneca Plc Alcohol Addiction Therapeutics Product
    Table 53. AstraZeneca Plc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 54. AstraZeneca Plc Recent Development
    Table 55. BioCorRx Inc Company Detail
    Table 56. BioCorRx Inc Business Overview
    Table 57. BioCorRx Inc Alcohol Addiction Therapeutics Product
    Table 58. BioCorRx Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 59. BioCorRx Inc Recent Development
    Table 60. Bionex Pharmaceuticals LLC Company Detail
    Table 61. Bionex Pharmaceuticals LLC Business Overview
    Table 62. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product
    Table 63. Bionex Pharmaceuticals LLC Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 64. Bionex Pharmaceuticals LLC Recent Development
    Table 65. Cerecor Inc Company Detail
    Table 66. Cerecor Inc Business Overview
    Table 67. Cerecor Inc Alcohol Addiction Therapeutics Product
    Table 68. Cerecor Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 69. Cerecor Inc Recent Development
    Table 70. Chronos Therapeutics Ltd Company Detail
    Table 71. Chronos Therapeutics Ltd Business Overview
    Table 72. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product
    Table 73. Chronos Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 74. Chronos Therapeutics Ltd Recent Development
    Table 75. Corcept Therapeutics Inc Company Detail
    Table 76. Corcept Therapeutics Inc Business Overview
    Table 77. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product
    Table 78. Corcept Therapeutics Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 79. Corcept Therapeutics Inc Recent Development
    Table 80. Curemark LLC Company Detail
    Table 81. Curemark LLC Business Overview
    Table 82. Curemark LLC Alcohol Addiction Therapeutics Product
    Table 83. Curemark LLC Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 84. Curemark LLC Recent Development
    Table 85. Eli Lilly and Company Company Detail
    Table 86. Eli Lilly and Company Business Overview
    Table 87. Eli Lilly and Company Alcohol Addiction Therapeutics Product
    Table 88. Eli Lilly and Company Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 89. Eli Lilly and Company Recent Development
    Table 90. Ethypharm SA Company Detail
    Table 91. Ethypharm SA Business Overview
    Table 92. Ethypharm SA Alcohol Addiction Therapeutics Product
    Table 93. Ethypharm SA Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 94. Ethypharm SA Recent Development
    Table 95. H. Lundbeck A/S Company Detail
    Table 96. H. Lundbeck A/S Business Overview
    Table 97. H. Lundbeck A/S Alcohol Addiction Therapeutics Product
    Table 98. H. Lundbeck A/S Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 99. H. Lundbeck A/S Recent Development
    Table 100. Heptares Therapeutics Ltd Company Detail
    Table 101. Heptares Therapeutics Ltd Business Overview
    Table 102. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product
    Table 103. Heptares Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 104. Heptares Therapeutics Ltd Recent Development
    Table 105. Indivior Plc Company Detail
    Table 106. Indivior Plc Business Overview
    Table 107. Indivior Plc Alcohol Addiction Therapeutics Product
    Table 108. Indivior Plc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 109. Indivior Plc Recent Development
    Table 110. Kinnov Therapeutics SAS Company Detail
    Table 111. Kinnov Therapeutics SAS Business Overview
    Table 112. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product
    Table 113. Kinnov Therapeutics SAS Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 114. Kinnov Therapeutics SAS Recent Development
    Table 115. Kyorin Pharmaceutical Co Ltd Company Detail
    Table 116. Kyorin Pharmaceutical Co Ltd Business Overview
    Table 117. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product
    Table 118. Kyorin Pharmaceutical Co Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 119. Kyorin Pharmaceutical Co Ltd Recent Development
    Table 120. Lohocla Research Corp Company Detail
    Table 121. Lohocla Research Corp Business Overview
    Table 122. Lohocla Research Corp Alcohol Addiction Therapeutics Product
    Table 123. Lohocla Research Corp Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 124. Lohocla Research Corp Recent Development
    Table 125. Montisera Ltd Company Detail
    Table 126. Montisera Ltd Business Overview
    Table 127. Montisera Ltd Alcohol Addiction Therapeutics Product
    Table 128. Montisera Ltd Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 129. Montisera Ltd Recent Development
    Table 130. Omeros Corp Company Detail
    Table 131. Omeros Corp Business Overview
    Table 132. Omeros Corp Alcohol Addiction Therapeutics Product
    Table 133. Omeros Corp Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 134. Omeros Corp Recent Development
    Table 135. Opiant Pharmaceuticals Inc Company Detail
    Table 136. Opiant Pharmaceuticals Inc Business Overview
    Table 137. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product
    Table 138. Opiant Pharmaceuticals Inc Revenue in Alcohol Addiction Therapeutics Business (2019-2024) & (US$ Million)
    Table 139. Opiant Pharmaceuticals Inc Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alcohol Addiction Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Alcohol Addiction Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. CM-1212 Features
    Figure 4. CTDP-002 Features
    Figure 5. A-705253 Features
    Figure 6. ABT-436 Features
    Figure 7. ADX-71441 Features
    Figure 8. Others Features
    Figure 9. Global Alcohol Addiction Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Alcohol Addiction Therapeutics Market Share by Application: 2023 VS 2030
    Figure 11. Hospital Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Others Case Studies
    Figure 14. Alcohol Addiction Therapeutics Report Years Considered
    Figure 15. Global Alcohol Addiction Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Alcohol Addiction Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Alcohol Addiction Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global Alcohol Addiction Therapeutics Market Share by Players in 2023
    Figure 19. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcohol Addiction Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Alcohol Addiction Therapeutics Revenue in 2023
    Figure 21. North America Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Alcohol Addiction Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Alcohol Addiction Therapeutics Market Share by Country (2019-2030)
    Figure 27. Germany Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Alcohol Addiction Therapeutics Market Share by Region (2019-2030)
    Figure 35. China Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Alcohol Addiction Therapeutics Market Share by Country (2019-2030)
    Figure 43. Mexico Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Alcohol Addiction Therapeutics Market Share by Country (2019-2030)
    Figure 47. Turkey Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Alcohol Addiction Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. AstraZeneca Plc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 50. BioCorRx Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 51. Bionex Pharmaceuticals LLC Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 52. Cerecor Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 53. Chronos Therapeutics Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 54. Corcept Therapeutics Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 55. Curemark LLC Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 56. Eli Lilly and Company Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 57. Ethypharm SA Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 58. H. Lundbeck A/S Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 59. Heptares Therapeutics Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 60. Indivior Plc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 61. Kinnov Therapeutics SAS Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 62. Kyorin Pharmaceutical Co Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 63. Lohocla Research Corp Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 64. Montisera Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 65. Omeros Corp Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 66. Opiant Pharmaceuticals Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Alcohol and Drug Abuse Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alcoholic Hepatiti Drug Market Research Report 2024
Global Drugs of Abuse Testing Market Research Report 2024
Global Drug Abuse Screening Market Research Report 2025
Global Drug of Abuse Screening Market Research Report 2025
Global Nicotine Addiction Treatment Market Research Report 2025
Global Drugs of Abuse Analysis Controls Market Research Report 2024
Opioid Dependence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Online Opioid Addiction Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs of Abuse Test Kit Market Research Report 2025
Global Liver Failure Therapeutics Market Research Report 2025
Global General Anxiety Disorder Therapeutics Market Research Report 2025
Global Fermented BCAA Market Research Report 2025
Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cancer Treatment Drug Market Research Report 2025
Nicotine Addiction Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cirrhosis Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Candidiasis Therapeutics Market Research Report 2024
Global Specific Learning Disability Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions